巴里·威尔逊（Barry Wilson）
美敦力国际事务高级副总裁，大中华区总裁

    2006年5月被任命为美敦力大中华区总裁，同时，他担任美敦力国际事务高级副总裁。
    威尔逊于1995年加入美敦力，担任欧洲、中东和非洲区总裁。1997年，他被选为美敦力高级副总裁并加入执行委员会。2000年，加拿大和拉美被纳入他的责任范围，2001年他被提升为美敦力国际总裁。2005年8月，被任命为国际事务高级副总裁。
    威尔逊直接向美敦力首席执行官和董事长汇报。他的责任是与关键的政治领导人和政策制定人一起，改善美国以外的病人获得美敦力产品的渠道，并发掘合作伙伴、寻找联盟和购并对象。
    威尔逊曾担任美国Cyanamid 公司的Lederle分部国际总裁，这家以研究为基础的生命科学公司于1995年和American Home Products合并。在此之前，他是百时美施贵宝公司的欧洲总裁。
    1967年，威尔逊先生从宾夕法尼亚大学沃顿商学院毕业，随即在纽约辉瑞总部开始了职业生涯，后去南非接受第一个国际任务。此后,，他领导了比利时、德国、印度、香港、日本、等国家和地区的业务，在国际管理方面积累了丰富的经验。1989年，他成为施贵宝加拿大、太平洋、中东非和东欧地区总裁，后来成为欧洲总裁。
    威尔逊先生还担任过包括博士伦等在内的国际知名公司的董事会成员，在2002年至2004年担任了代表欧洲医疗技术产品制造商和销售商的泛欧商业组织Eucomed的董事长，现在是该组织的荣誉董事长。威尔逊先生还是美国医疗器材协会AdvaMed的高级顾问。
    威尔逊先生以优异成绩毕业于英国剑桥大学，获学士和硕士学位；在宾夕法尼亚大学沃顿商学院获得工商管理硕士学位。
    Barry Wilson was appointed Senior Vice President, International Affairs on August 1, 2005. He joined Medtronic as President Europe, Middle East and Africa in 1995, directing operations in these areas and serving on the company’s Operating Committee. In 1997, he was elected a Senior Vice President of Medtronic, Inc. and joined the Executive Committee. In 2000 Canada and Latin America were added to his responsibilities and in 2001 he was promoted to President of Medtronic International.
    In his new role, reporting to the CEO and Chairman, Mr. Wilson will work with key political and health policy leaders to improve patient access to the company's products and therapies outside of the U.S. He will be collaborating with the major medical device industry trade associations and interfacing with key regional and national professional associations regarding adoption of guidelines in key disease and therapy areas.
    Mr. Wilson is a former President, International of the Lederle Division of the American Cyanamid Company, a research-based life sciences company that merged with American Home Products in 1995. Prior to this, he was President, Europe of the Bristol-Myers Squibb Company.
Upon graduation from The Wharton School at the University of Pennsylvania in 1967, Mr. Wilson began his career at Pfizer Inc. headquarters in New York before taking up his first international assignment in South Africa. With Pfizer, he went on to posts in Belgium, Germany, India, Hong Kong, Japan, the UK, and South Korea. He joined Squibb in 1980 as Vice President for the Japan/Pacific Region, based in Hong Kong. In 1984, he was appointed Vice President, Western Hemisphere (Canada and Latin America) and moved to company headquarters in Princeton, New Jersey. In 1987, he became President, Intercontinental (Japan, the Pacific, Latin America, Iberia and Middle East/Africa). As President Bristol-Myers Squibb Intercontinental in 1989, Mr. Wilson assumed responsibility for the newly merged businesses of Bristol-Myers and Squibb in Canada, Pacific, Middle East/Africa and Eastern Europe prior to being named President Europe of Bristol-Myers Squibb in 1991.
    In January 2003 Mr. Wilson was appointed to the Board of Directors of Bausch & Lomb. Previously, he served as a Director of Mallinckrodt, Inc. From 2000-2004, Mr. Wilson was Chairman of Eucomed, the pan-European trade association that represents the manufacturers and distributors of medical technology products in Europe. He is now Honorary Chairman of Eucomed. Mr. Wilson also serves as a Senior Advisor to AdvaMed, the U.S. medical device association.
Mr. Wilson was Chairman of the Lake Geneva Chapter and a member of the Senior Advisory Council of the Swiss-American Chamber of Commerce from June 2004-July 2005 having also served as a Vice President from 2001-2004 and a member of the Board since 1997. For eight years he was a Director of the Wharton School European Board and was a former Chairman, Asia/Pacific and Vice Chairman, Europe of the Pharmaceutical Research and Manufacturers Association of America.
Mr. Wilson holds a B.A. (Hons), M.A. from Cambridge University, England and an M.B.A from The Wharton School, University of Pennsylvania.